Investors / filer profile

Cagnoni Pablo J

President, Global Head of R&D

active in 1 company

Pro
Bought: Pro
Sold: 9
Filings: 1
Companies: 2026-08-19
Last filed

EDGAR · CIK 0001205703 ↗

Track record

How each disclosed position did against the S&P ~6 months later

No positions we can measure against the market yet — outcomes appear once a disclosed buy is ~6 months old.

Disclosed positions

Estimated from their latest filings — positions may have changed since

Estimated positions from their latest filingsPro →

Activity

Open-market buy & sell volume

BuySell

Total +$0.0000 bought · −$5.84M sold

All filings on record

Every Form 4 transaction we track for this filer


INCYINCYTE CORP	Sell $1.36M · 10,801 sh	2026-08-19	—
INCYINCYTE CORP	Sell $1.30M · 10,803 sh	2026-08-12	—
INCYINCYTE CORP	Sell $1.31M · 10,640 sh	2026-08-05	—
INCYINCYTE CORP	Sell $1.88M · 18,668 sh	2026-02-19	—
INCYINCYTE CORP	Exercise $341.1K · 5,575 sh	2026-02-19	—
INCYINCYTE CORP	Exercise $808.6K · 13,093 sh	2026-02-19	—
INCYINCYTE CORP	Grant — · 17,538 sh	2025-07-15	—
INCYINCYTE CORP	Tax $179.4K · 2,628 sh	2025-07-15	—
INCYINCYTE CORP	Tax $89.6K · 1,280 sh	2025-07-14	—

INCYSell

2026-08-19 · INCYTE CORP

$1.36M

—

INCYSell

2026-08-12 · INCYTE CORP

$1.30M

—

INCYSell

2026-08-05 · INCYTE CORP

$1.31M

—

INCYSell

2026-02-19 · INCYTE CORP

$1.88M

—

INCYExercise

2026-02-19 · INCYTE CORP

$341.1K

—

INCYExercise

2026-02-19 · INCYTE CORP

$808.6K

—

INCYGrant

2025-07-15 · INCYTE CORP

17,538

—

INCYTax

2025-07-15 · INCYTE CORP

$179.4K

—

INCYTax

2025-07-14 · INCYTE CORP

$89.6K

—

9 filingsEvery Form 4 on record, with outcomesPro →

Outcomes measure each position — the first buy in a stock and every buy within 182 days — against the closing price ~6 months (120 trading days) later, with the S&P 500 over the same span for context. Pre-scheduled 10b5-1 plan trades are excluded from the record. Positions are estimated from the latest reported post-transaction holdings, split-adjusted, at the latest close. Built from SEC Form 4 filings and market prices — past outcomes, not predictions or advice.